From October 19–22 in 2025, MacroLux participated in the 34th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE 2025), held in Istanbul, Türkiye.
From July 3rd to 5th, 2025, the UROFAIR 2025, hosted by the Singapore Urological Association, brought together over a hundred leading experts in urology from dozens of countries in Singapore, showcasing the latest advancements in the field.
LAS VEGAS, NV – April 26-29, 2025 – The 120th Annual Meeting of the American Urological Association (AUA) was held in Las Vegas, Nevada, bringing together leading experts from around the world to showcase the latest advancements in the field of urology.
From March 21 to 24, 2025, the 40th European Association of Urology Congress (EAU25) will be held in the capital of Spain, featuring Europe’s largest urology event. MacroLux showcased its high-performance urology products in Madrid.
MacroLux Medical Technology Co., Ltd. announced the successful close of its Series B+ financing round led by B Capital. The funding will support MacroLux Medical’s continued global expansion and accelerate growth in the disposable endoscope market.
From November 11 to 14, 2024, MacroLux Medical participated in Medica 2024 at the Düsseldorf Exhibition Center in Germany. This event is a significant occasion in the global medical technology field, attracting top medical technology and innovative achievements from around the world.
We are very pleased to announce that our company (hereinafter referred to as MacroLux Medical) recently announced the completion of over 14 million dollars in Series B financing. The round was led by Yuanbio Venture Capital, with continued support from existing shareholders Legend Capital and Dalton Venture, and Haoyue Capital acted as the exclusive financial advisor.
MacroLux is a company dedicated to endoscopic diagnosis and treatment, focused on providing innovative and reliable medical solutions to healthcare professionals around the world. We are focusing on the endoscopic intervention therapy market and prioritize the development of single-use electronic endoscope products.
